Bisoprolol fumarate/Perindopril arginine

富马酸比索洛尔/精氨酸培哚普利

Report date: 2022/01/14 13:23:58

Base Information

Drug NameBisoprolol fumarate/Perindopril arginine
Drug Alias NamePerindopril arginine+Bisoprolol fumarate精氨酸培哚普利/富马酸比索洛尔精氨酸培哚普利+富马酸比索洛尔Bisoprolol fumarate+Perindopril argininePerindopril arginine/Bisoprolol fumarate +[11
ClassificationSmall molecules
Mechanisms of ActionAngiotensin-converting enzyme inhibitorsBeta-1 adrenergic receptor antagonists
TargetsAngiotensin-converting enzymeBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertensionCoronary DiseaseHeart Failure
Global Approved IndicationsHypertensionCoronary DiseaseHeart Failure
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2016/01/01
Country/TerritoryEU
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesLaboratoires Servier
China Registration ClassN/A

Develop Information

Active CompaniesLaboratoires Servier
Inactive CompaniesN/A
Active IndicationsHypertensionCoronary DiseaseHeart Failure
Inactive IndicationsN/A

Other Information

ATC CodeC07FB07
Related LinksN/A